Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2011; 17(9): 1185-1191
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1185
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1185
Subgroups | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
All patients (n = 99) | 65.40% (55.4-74.9) | 93.60% (87.3-97.7) | 91.90% (84.7-96.4) | 71.00% (60.7-79.4) |
Patients with leukopenia (n = 56) | 68.60% (54.0-79.7) | 100% (93.6-100) | 100% (93.6-100) | 65.60% (52.2-78.2) |
Patients without leukopenia (n = 43) | 58.80% (42.1-73.0) | 88.50% (74.9-96.1) | 76.90% (61.4-88.2) | 76.70% (61.4-88.2) |
HIV-infected patients (n = 45) | 63.60% (48.8-78.1) | 100% (92.2-100) | 100% (92.2-100) | 50.00% (35.8-66.3) |
Non-HIV-infected patients (n = 54) | 68.40% (54.5-80.5) | 91.40% (79.7-96.9) | 81.30% (68.6-90.7) | 84.20% (70.7-92.1) |
HIV-infected patients with CD4 count < 50 (n = 22) | 61.90% (40.7-82.8) | 100% (84.6-100) | 100% (84.6-100) | 11.10% (1.12-29.2) |
HIV-infected patients with CD4 count ≥ 50 (n = 23) | 66.70% (42.7-83.6) | 100% (85.2-100) | 100% (85.2-100) | 73.30% (51.6-89.8) |
- Citation: Nagata N, Kobayakawa M, Shimbo T, Hoshimoto K, Yada T, Gotoda T, Akiyama J, Oka S, Uemura N. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol 2011; 17(9): 1185-1191
- URL: https://www.wjgnet.com/1007-9327/full/v17/i9/1185.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i9.1185